Metraipolis › archive › dc_722797cde62c
LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41720851
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T14:17:39.930Z
- SHA-256 of the archived text
62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c- Stable URL of this page
https://metraipolis.com/documento/dc_722797cde62c
How to cite
LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851 — Europe PMC (en), https://europepmc.org/article/MED/41720851 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_722797cde62c (Metraipolis archive dc_722797cde62c, sha256 62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c)
BibTeX
@misc{dc722797cde62c,
title = {LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers — Europe PMC PMID:41720851},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41720851},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_722797cde62c; sha256 62eb4db2f7abd0a3ab0982518bca5bb9846aa5c1738fa27f67dff097ee4a316c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41720851. Agents can read the archived copy with the MCP tool read_document.